Reduction of Pd° and decomposition of palladium oxide supported on γ-alumina were studied at atmospheric pressure under different atmospheres (H(2), CH(4), He) over a 4 wt% Pd/Al(2)O(3) catalyst (mean palladium particle size: 5 nm with 50% of small particles of size below 5 nm). During temperature programmed tests (reduction, decomposition and oxidation) the crystal domain behaviour of the PdO/Pd° phase was evaluated by in situ Raman spectroscopy and in situ XRD analysis. Under H(2)/N(2), the reduction of small PdO particles (<5 nm) occurs at room temperature, whereas reduction of larger particles (>5 nm) starts at 100 °C and is achieved at 150 °C. Subsequent oxidation in O(2)/N(2) leads to reoxidation of small crystal domain at ambient temperature while oxidation of large particles starts at 300 °C. Under CH(4)/N(2), the small particle reduction occurs between 240 and 250 °C while large particle reduction is fast and occurs between 280 and 290 °C. Subsequent reoxidation of the catalyst reduced in CH(4)/N(2) shows that small and large particle oxidation of Pd° starts also at 300 °C. Under He, no small particle decomposition is observed probably due to strong interactions between particles and support whereas large particle reduction occurs between 700 and 750 °C. After thermal decomposition under He, the oxidation starts at 300 °C. Thus, the reduction phenomenon (small and large crystal domain) depends on the nature of the reducing agent (H(2), CH(4), He). However, whatever the reduction or decomposition treatment or the crystal domain, Pd° oxidation starts at 300 °C and is completed only at temperatures higher than 550 °C. Under lean conditions, with or without water, the palladium consists of reduced sites of palladium (Pd°, Pd(δ+) with δ < 2 or PdO(x) with x < 1) randomly distributed on palladium particles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.